Key messages from scientific research that's ready to be acted on
Got It, Hide thisVeronese N, Stubbs B, Maggi S, et al. Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis. J Am Geriatr Soc. 2017;65:1763-8.
In older adults who do not have cognitive impairment or dementia, does low-dose aspirin slow cognitive impairment?
As people age, it is natural for memory to get worse. Mild cognitive impairment can include problems with thinking, memory, language, and judgment that are noticeable. Dementia is more serious cognitive impairment that interferes with daily living. Many people use low-dose aspirin to prevent cardiovascular diseases. Since cardiovascular diseases are risk factors for cognitive impairment and dementia, it is possible that aspirin might prevent or slow worsening of cognitive function.
The researchers did a systematic review, searching for studies that were published up to September 2016. They found 3 randomized controlled trials with 10,037 people who were, on average, 67 years of age. 74% were women. People were followed for 3 to 10 years.
The key features of the studies were as follows:
The quality of the trials was good.
People who took aspirin did not differ from those who did not for global cognitive test scores and verbal memory scores.
Low-dose aspirin improved executive function (ability to manage time, pay attention, switch focus) and fluency (ability to speak accurately and quickly) test scores.
More people who used low-dose aspirin had stomach-related adverse effects.
In people who do not have cognitive impairment or dementia, taking low-dose aspirin does not reduce cognitive impairment.
Outcomes | Effect of low-dose aspirin |
Global cognitive test scores | No differences between groups. |
Verbal memory tests | No differences between groups. |
Executive function and fluency tests | Low-dose aspirin improved scores. |
Adverse effects | Low-dose aspirin increased stomach-related side-effects. |
Support for the Portal is largely provided by the Labarge Optimal Aging Initiative. AGE-WELL is a contributing partner. Help us to continue to provide direct and easy access to evidence-based information on health and social conditions to help you stay healthy, active and engaged as you grow older. Donate Today.